Results 121 to 130 of about 4,816,902 (277)

Novel Psychoactive Substances and legislative harmonization in Europe: addressing a extremely elusive public health threat. [PDF]

Acta Biomed, 2023
Umani Ronchi F.
europepmc   +1 more source

The Psychometric Properties and Clinical Usefulness of the Difficulties in Emotion Regulation Scale in Forensic Settings

Journal of Clinical Psychology, EarlyView.
ABSTRACT Objective The Difficulties in Emotion Regulation Scale (DERS) is a widely used measure of emotion dysregulation across clinical contexts. However, its psychometric properties and clinical utility have not been thoroughly examined in forensic populations.
Adam Meddeb, Märta Wallinius, Johan Berlin, Natalie Laporte, Malin Hildebrand Karlén, Claudia Mazzeschi, Elisa Delvecchio, Patrizia Velotti, Carlo Garofalo   +8 more
wiley   +1 more source

Reports of Adverse Events Associated with Use of Novel Psychoactive Substances, 2017-2020: A Review. [PDF]

J Anal Toxicol, 2022
Mohr ALA, Logan BK, Fogarty MF, Krotulski AJ, Papsun DM, Kacinko SL, Huestis MA, Ropero-Miller JD.   +7 more
europepmc   +1 more source

Possible Signals of Ocular Disorders Associated with Gabapentinoids: A Three-Arm Study

Pharmaceuticals
Background: Gabapentinoids (gabapentin and pregabalin) are medications used to treat epilepsy and diabetic neuropathy. Reports of gabapentinoid-associated adverse drug reactions (ADRs) are increasing.
Mya Murray, Amira Guirguis, Paul Deslandes, John Martin Corkery, Stefania Chiappini, Mariacristina Parravano, Fabrizio Schifano   +6 more
doaj   +1 more source

The challenge of synthetic drugs in East and South-East Asia and Oceania [PDF]

, 2015
The demand for synthetic drugs in East and Southeast Asia and Oceania continues to rise, while rapid economic integration is creating new opportunities for transnational criminal groups to expand the illicit drug trade, warns the United Nations Office on
Justice Tettey
core  

Irritability in preschool children with attention‐deficit/hyperactivity disorder: Analysis of family environmental factors

JCPP Advances, EarlyView.
Abstract Background Irritability affects one‐third of children and adolescents with attention‐deficit/hyperactivity disorder (ADHD) and is associated with negative outcomes. The family environment plays a prominent role in the child's development, and therefore on the risk for irritability, especially during the preschool period.
Analin Ono Baraniuk, Giovanni Abrahão Salum, David Daley, Erika Mendonça de Morais, Filipe Jaeger Zabala, Luiz Eduardo de Souza, Guilherme V. Polanczyk, Luisa Shiguemi Sugaya   +7 more
wiley   +1 more source

Novel Psychoactive Substances: The Razor's Edge between Therapeutical Potential and Psychoactive Recreational Misuse. [PDF]

Medicines (Basel), 2022
Correia B, Fernandes J, Botica MJ, Ferreira C, Quintas A.   +4 more
europepmc   +1 more source

Signal Detection of Depression and Suicidality Associated with Finasteride and Dutasteride: Updated Pharmacovigilance Evidence and Recommendations for Comprehensive Psychiatric Assessment

Brain Sciences
Background/Objectives: Finasteride and dutasteride are 5α-reductase inhibitors that block the conversion of testosterone to dihydrotestosterone, reducing androgenic stimulation of tissues such as the prostate and hair follicles.
Stefania Chiappini, John Martin Corkery, Amira Guirguis, Alessio Mosca, Mya Murray, Davide Arillotta, Luigi Dattoli, Giovanni Martinotti, Stefania Bonaccorso, Fabrizio Schifano, Nicolò Schifano   +10 more
doaj   +1 more source

Implications of attention‐deficit/hyperactivity disorder diagnostic timing on mental health service utilisation in young adult females: A population‐based record linkage cohort study

JCPP Advances, EarlyView.
Abstract Background Sex differences in the frequency and timing of attention‐deficit/hyperactivity disorder (ADHD) diagnosis exist. While there are multiple known individual and wider consequences for young females with delayed or undiagnosed ADHD, little is known about mental health service utilisation (HSU) impacts.
Estelle Alderson, Nicholas Bowden, Laurie McLay, Ben Beaglehole, Philip J. Schluter   +4 more
wiley   +1 more source

Knowledge and Use of Novel Psychoactive Substances in an Italian Sample with Substance Use Disorders. [PDF]

Int J Environ Res Public Health, 2022
Dal Farra D, Valdesalici A, Zecchinato G, De Sandre A, Saccon D, Simonato P, Corazza O, Martinotti G, Smith AL, Solmi M.   +9 more
europepmc   +1 more source